medigraphic.com
ISSN 1405-1710 (Impreso)

2015, Número 2

<< Anterior Siguiente >>

Rev Cent Dermatol Pascua 2015; 24 (2)


Sarna costrosa en una lactante con dermatitis atópica. Revisión de la literatura

López-Cepeda LD, Martínez GEC

Idioma: Español
Referencias bibliográficas: 39
Paginas: 56-63
Archivo PDF: 341.08 Kb.


RESUMEN

La escabiasis es una ectoparasitosis causada por el ácaro Sarcoptes scabiei variedad hominis, que se transmite por contacto directo o por fómites; la dermatosis es característica e intensamente pruriginosa. La escabiasis costrosa o sarna noruega, es una variedad atípica, caracterizada por intensa reacción inflamatoria, lesiones escamocostrosas, hiperqueratósicas y poco pruriginosas con tendencia a la generalización, que se presenta generalmente en personas inmunocomprometidas, ancianos, niños o pacientes que han estado bajo tratamiento con esteroides o inmunosupresores. Presentamos el caso de una lactante con dermatitis atópica y sarna noruega, que requirió para sanar varios ciclos de tratamiento tópico.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gunning K, Pippit K, Kiraly B et al. Pediculosis and scabies: a treatment update. Am Fam Physician. 2012; 86: 535-541.

  2. Claire F. Epidemiology of scabies. Curr Opin Infect Dis. 2013; 26: 123-126.

  3. Chorng-Jang L, Chun-Lung W, Hui-Ying C et al. Risk factors for delayed diagnosis of scabies in hospitalized patients from long-term care facilities. J Clin Med Res. 2011; 3: 72-77.

  4. Makigami K, Ohtaki N, Ishii N et al. Risk factors for recurrence of scabies: a retrospective study of scabies patients in a long-term care hospital. J Dermatol. 2011; 38: 874-879.

  5. McCarthy JS, Kemp DJ, Walton SF et al. Scabies: more than just an irritation. Postgrad Med J. 2004; 80: 382-387.

  6. Otero L, Varela JA, Espinoza E et al. Sarcoptes scabiei in a sexuality transmitted infections unit: a 15 year study. Sex Transm Dis. 2004; 31: 761-765.

  7. Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006; 354: 1718-1727.

  8. Morales L, Arenas R. Escabiosis. Tratamiento de 40 pacientes con ivermectina oral. DCMQ. 2006; 4: 237-241.

  9. Chouela E, Abeldaño A, Pellerano G et al. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol. 2002; 3: 9-18.

  10. Bergström FC, Reynolds S, Johnstone M, Pike RN et al. Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol. 2009; 182: 7809-7817.

  11. Holt D, Fischer K. Novel insights into an old disease: recent developments in scabies mite biology. Curr Opin Infect Dis. 2013; 26: 110-115.

  12. Huynth TH, Norman RA. Scabies and pediculosis. Dermatol Clin. 2004; 22: 7-11.

  13. Parish LC, Lomholt G. Crusted scabies alias Norwegian scabies. Int J Dermatol. 1976; 15: 747-748.

  14. Morgan MS, Arlian LG. Response of human skin equivalents to Sarcoptes scabiei. J Med Entomol. 2010; 47: 877-883.

  15. Mullins JS, Arlian LG, Morgan MS. Extracts of Sarcoptes scabiei De Geer down modulate secretion of IL-8 by skin keratinocytes and fibroblasts and of GM-CSF by fibroblasts in the presence of proinflammatory cytokines. J Med Entomol. 2009; 46: 845-851.

  16. Ríos-Yuil JM, Mercadillo-Pérez P, Yuil-De Ríos E, Ríos-Castro M. Actualización en escabiasis con insistencia en los aspectos inmunológicos de la infestación. Dermatol Rev Mex. 2012; 56: 404-413.

  17. Heukelbach J, Feldmeier H. Scabies. Lancet. 2006; 367: 1767-1774.

  18. Kortono F, Edward W, Lee MD et al. Crusted Norwegian scabies in an adult with Langerhans cell histiocytosis: mishaps leading to systemic chemotherapy. Arch Dermatol. 2007; 143: 626-628.

  19. Oh S, Vandergriff T. Scabies of the nail unit. Dermatology Online Journal. 2014; 20: 16.

  20. Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect. 2005; 50: 375-381.

  21. Wong SS, Woo PC, Yen KY. Unusual laboratory findings in a case of Norwegian scabies provided a clue to diagnosis. J Clin Microbiol. 2005; 43: 2542.

  22. Chih-Chieh C, Sung-Jan L, Ya-Chi C et al. Infestation by Norwegian scabies. CMAJ. 2009; 181: 28.

  23. Amado S. Lecciones de dermatología. 15 edición. México: Editores Méndez; 2008. pp. 231-232.

  24. Mahé A, Faye O, N’Diaye HT et al. Definition of an algorithm for the management of common skin diseases at primary health care level in sub-Saharan Africa. Trans R Soc Trop Med Hyg. 2005; 99: 39.

  25. Dupuy A, Dehen L, Bourrat E et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol. 2007; 56: 53.

  26. Walter B, Heukelbach J, Fengler G et al. Comparison of dermoscopy, skin scraping, and the adhesive tape test for the diagnosis of scabies in a resource-poor setting. Arch Dermatol. 2011; 147: 468.

  27. Harman M, Ucmak D, Akkurt ZM, Türkcü G. Hypereosinophilia in erythrodermic psoriasis: superimposed scabies. Cutis. 2014; 94: 156-159.

  28. Karthikeyan K. Treatment of scabies: newer perspectives. Postgrand Med J. 2005; 81: 7-11.

  29. Alonzo PL et al. Dermatitis de contacto alérgica al níquel. Rev Cent Dermatol Pascua. 2006; 15: 99-102.

  30. Bitman LM, Rabinowitz AD. Hyperkeratotic plantar plaques in HIV positive patient. Crusted scabies. Localized to soles. Arch Dermatol. 1998; 134: 1022-1023.

  31. Singalavanija S, Limpongsanurak W, Soponsakunkul S. A comparative study between 10 percent sulfur ointment and 0.3 percent gamma benzene hexachloride gel in the treatment of scabies in children. J Med Assoc Thai. 2003; 86 Suppl: 531-536.

  32. Strong M, Johnstone PW. Intervenciones para el tratamiento de la escabiasis (revisión de Cochrane traducida). En: La biblioteca Cochrane Plus. 2008; Número 2. Oxford: update software Ltd. Consultada diciembre 2011. Disponible en: http://www.uptodate-software.com.

  33. Goldust M, Rezaee E, Hemayat S. Treatment of scabies: comparison of permethrin 5% versus ivermectin. J Dermatol. 2012; 39: 545-547.

  34. Workowski KA, Berman S. Centers for disease control and prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010 [published correction appears in MMWR Recomm Rep 2011. 60(1):18]. MMWR Recomm Rep. 2010; 59 (RR-12): 1-110.

  35. Galván JL. Historia de la sarna. Piel. 2004; 19: 533-537.

  36. Behera SK, Dimri U, Singh S et al. The curative and antioxidative efficiency of ivermectin and ivermectin + vitamin E-selenium treatment on canine Sarcoptes scabiei infestation. Vet Res Commun. 2011; 35: 237-244.

  37. Walton SF, McBroom J, Mathews JD, Kemp DJ, Currie BJ. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis. 1999; 29: 1226-1230.

  38. Campillos-Paez MT et al. Escabiosis: revisión y actualización. Medi Fam Online. 2002; 12: 40-54.

  39. Diaz JH. Scabiei. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 7th ed. Philadelphia, Pa: Churchill Livingstone Elsevier; 2009. pp. 3633-3636.




2020     |     www.medigraphic.com